Metastatic Prostate Cancer: New Studies Indicate Improvement with PC Hope
Two new studies indicate that for men with prostate cancer, PC Hope is associated with significant improvements in quality of life, reductions in patients’ pain rating, and a decline in PSA levels without major side effects.
(PRWEB) November 18, 2004 -- Nutrition 2000 is proud to announce the results
of two recent studies conducted on the formulation of its product for prostate cancer, PC Hope. PC Hope, a dietary supplement
containing various sitosterols, quercetin and sterolins, extracts from Saw
Palmetto, Scutellaria, Ginseng, Skullcap, Reishi, Ginger, Stinging Nettle and
Pygeum, is becoming popular among patients with prostate cancer and can be
used as complementary treatment in various stages of the disease.
The
two prostate cancer studies led in by Dr U. Kratzer of the Urology
Clinic in Trostberg, Germany, and Dr. B. Pfeifer of the Aeskulap Cancer Center
in Brunnen, Switzerland, conclude that the herbal blend in PC Hope significantly
reduces PSA and pain of metastatic disease, thereby improving quality of life
for prostate cancer patients without the detrimental side effects
seen with other drug regimens.
The first study, initiated in December
2001, evaluated a total of 84 men between the ages of 56 and 75 with
ablation-resistant metastatic prostate cancer for
possible toxic and beneficial effects from using the PC Hope formulation. The
men received supplemental treatment with PC Hope formulation (2700 mg daily for
the first month, 1800mg daily for the second month, 1200 mg daily in the third
month, and between 900 to 1200 mg from the fourth month on) for a total
follow-up of 16 months. Hormonal therapy was continued throughout the trial to
avoid the known withdrawal effect of anti-androgen on PSA. The study revealed
that 60% of the 84 prostate cancer patients
reported improvement of at least 30% in their overall daily
functioning.
A second study, aimed at determining clinical efficacy and
side effect profile of the PC Hope formulation intake, was evaluated
prospectively utilizing prostate cancer patient
questionnaires, physician-patient interviews, and laboratory data analysis
during a 12 month follow-up period of 178 men between the ages of 52 and 75.
About half of the study patients (88) had undergone radical prostatectomy as
initial treatment for their prostate cancer followed
by hormone ablative therapy upon recurrence of their disease or metastasis.
Slightly more than one quarter of the prostate cancer patients
(46) had prior external radiation therapy followed by hormone ablative therapy,
and the remainder of the prostate cancer patients
(44) underwent either surgical or chemical castration as their initial therapy.
The study indicated that about two-thirds of the hormone refractory prostate cancer patients responded with a greater than 50%
reduction in their serum PSA levels. Furthermore, at least 20% responded not
only with a durable PSA decline under the PC Hope formulation therapy, but also
showed evidence of decreasing volume of primary prostate cancer and
metastases. Although research revealed about 20% of the prostate cancer patients reported a slight increase of the
breasts, in particular at the higher dosage of the PC Hope formulation during
the first two months of the study, the breast enlargement was usually reversible
during the remainder of the study period when a lower maintenance dosage of the
PC Hope formulation was administered.
Larry Pope, President of Nutrition
2000, says, “Although the results are promising, we don’t want the public to
think that PC Hope is a magic bullet. Nevertheless, it is an effective
alternative for prostate cancer patients.”
Patients with hormone
refractory prostate cancer are reported to have a median survival of six
to twelve months, experts say. Experts also report that current therapeutic
regimens for prostate cancer have only shown transient palliative benefit
without increasing patient survivals, and most of these palliative therapies
have significant side effects. Prostate cancer patients
with such dismal prognoses are prone to seek alternative treatments, including
herbal remedies. Among such remedies, PC Hope has gained popularity due to
anecdotal reports about its benefits for hormone refractory prostate cancer patients. The results of both studies verify
some of those claimed benefits. For more detailed information concerning these
studies or to learn more about PC Hope please visit www.nutrition2000.com or
call 1-800-558-9697.
About Nutrition 2000
Nutrition
2000 offers some of the world's finest natural health products, herbal remedies,
and supplements for the treatment of prostate cancer,
pancreatic cancer, colon cancer, Candida, and more. Stocking a carefully
selected range of products made from the highest quality herbal extracts and
pharmaceutical-grade nutrient powders, they provide alternative natural remedies
to combat illnesses and common ailments. Nutrition 2000 delivers their message
and products to the United States, United Kingdom, and other countries around
the world.
# # #
Source : http://www.prweb.com/releases/2004/11/prweb180012.htm